Appointing Interns/Volunteers!!
You may know someone who is interested in volunteering working with GRAG team across Africa. Our volunteer program is open to everybody, both students, professional and non-professional. Read more
In the News
-
I’M CLEAN AND WANT TO STAY THAT WAY: HIV+ FOR HIV+
2013-03-20 -
Tackling poverty and disease with innovative health financing
2013-03-19 -
Widespread 'Test-And-Treat' HIV Policies Could Increase Dangerous Drug Resistance
2013-03-18 -
CHANGING MY MIND ON TREATMENT AS PREVENTION
2013-03-11 -
Two Global Issues: Homophobia and Hatred!
2013-02-06 -
Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data
2013-02-05 -
CHEST RESEARCH SPOTLIGHT: ALTERNATIVES TO MONOGAMY: RECONSIDERING “COMMITMENT” IN SAME-SEX MALE RELATIONSHIPS
2013-02-05 -
The Effect of Budget Sequestration on Global Health: Projecting the Human Impact in Fiscal Year 2013
2013-02-01 -
No woman should die giving life
2013-01-31 -
European HIV prevention webinar: The search for an HIV vaccine
2013-01-29
GRAG Team is welcoming Ms. Claire Ba, from African Leadership Academy --World Malaria Report 2012 --New WHO guidelines to better prevent HIV in sex workers --20-24 October 2013, Seventh EDCTP Forum in Dakar, Senegal --Women Deliver’s third global conference in May 2013 --
Learn more about Knowledge Management for Health --
Intravenous Drug Users
Intravenous Drug Users
16 million people or 0.4 percent of the global population aged 15 to 64 consumed opiate.
11 million or 0.3 percent of the population used heroin.
15 million people inject drugs in 148 countries.
GRAG will:
- Encourage the reduction of high-risk practices
- Step up prevention which has been relatively neglected in many countries
- Provide supportive services openly to a population whose risk behaviour is in any case illegal
- Provide effective interventions for Intravenous Drug Users (IDU) which can be beneficial to society as a whole
- Encourage IDU to switch to non-injecting drugs, which can reduce the risk of passing on HIV infection
- Promote voluntary HIV counselling and testing
- Promote STI prevention and treatment
- Engage governments and drug companies for a greater outcome in research
- Convince government and drug companies that reluctance to allow studies on IDU does not help in needs assessment study or undertake further research on such a group
